When is patient transfer indicated for the treatment of Burkitt lymphoma/Burkitt-like lymphoma (BL/BLL)?

Updated: Dec 20, 2019
  • Author: Ali H Kanbar, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Patients should be treated in a facility where the physicians are familiar with the use of intensive chemotherapy regimens. The facility should have access to hematopathology and physicians experienced in the prevention and treatment of renal failure from tumor lysis. Adequate blood product support should be available.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!